Sun, Jan 25, 2015, 12:20 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Halozyme Therapeutics, Inc. Message Board

  • rainbowmeow2003 rainbowmeow2003 Sep 30, 2013 10:39 AM Flag

    Recent run-up was largely short-covering in front of positive news

    The Phase 2 study will be a long wait. There is potential for large pharma partnerships once phase 2 results are de-risked, but were talking 2015 folks. Plus profitability or cash flow positive time frame impossible to predict at this point. So that's why investors like to sell the news in biotech...An easy call.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Sorry GUY....short covering was not the RUN UP. I'm sure there may have a bump for those who did cover shorts, but there wasn't that much covering needed. the oustanding short shares weren't as many as your stmnt would leave people to believe. that said the 10mill. pymnt was the catalyst, and the phase data coming to market. the 10mill $ payment even though it was expected, it proof that thr Roche relationship is (proof) in proving it's intention. finally, the pymnt reassures the product and roche in in-it to-win-it. So...buyers stepped in, and sure shorts covered, but they covered throughtout the days pullback, and this morning. this company is a great longer term play. short term through 2013 is a HOLD at this point or accum'late if you're long term. My 10yr brokerage career experience says, Sell the Dec. 13 or 14 $ calls agaisnt long positions, collect yourself some extra money, and watch 2014! Should be a good year. My technical analysis confirms my call strategy, and confirms the uptrend we're going to see (with a rising support level over $9. Buy on the pullbacks down to $8.55 - which maynot happen, so chose on your own when to buy. 2014, $13 and higher should be sustainable, unless phase data truely sux. GTLAL

      Sentiment: Hold

    • Really? HALO didn't find it impossible to predict profitability. Before the end of next year. Hope that helps.

 
HALO
13.87-0.14(-1.00%)Jan 23 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.